Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 93630
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.93630
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.93630
Figure 4 Effect of adding inhibitor-mir-29a-3p to cells in the normal glucose group or adding miR-29a-3p mimics to cells in the high glucose group on the expression of DNA methyl transferase 3A/3B.
A and C: Quantitative reverse transcription PCR for detecting the transfection efficiency; B and D: Western blotting to detect the expression of DNA methyl transferase 3A/3B (DNMT3A/3B) (n = 3). aP < 0.05. bP < 0.01. cP < 0.001. CON: Control group; HG: High glucose group; NC: Negative control.
- Citation: Yang Y, Chen Y, Tang JY, Chen J, Li GQ, Feng B, Mu J. MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B. World J Diabetes 2025; 16(4): 93630
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/93630.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.93630